As the Trump administration reevaluates its funding of medical research on tissue from aborted babies, pro-life groups are calling for National Institutes of Health (NIH) Director Francis Collins (pictured) to be rebuked or removed for continuing to defend the ethically-fraught practice.
The controversy began in August when a notice from the U.S. Food and Drug Administration (FDA) surfaced detailing a contract to the fetal tissue procurement firm Advanced Bioscience Resources, Inc. (ABR) to acquire “Tissue for Humanized Mice.” Dozens of pro-life leaders and House members successfully pressured the FDA and Department of Health and Human Services (HHS) to terminate the contract, but concerns remained over nearly $100 million in tax dollars that continued to pay for other research using tissue and organs from aborted babies.
Click here for more from Life Site News.